LLY

752.36

-0.66%↓

JNJ

151.72

+0.28%↑

UNH

304.64

+4.6%↑

ABBV

183.5

-0.25%↓

NVO

65.84

+2.33%↑

LLY

752.36

-0.66%↓

JNJ

151.72

+0.28%↑

UNH

304.64

+4.6%↑

ABBV

183.5

-0.25%↓

NVO

65.84

+2.33%↑

LLY

752.36

-0.66%↓

JNJ

151.72

+0.28%↑

UNH

304.64

+4.6%↑

ABBV

183.5

-0.25%↓

NVO

65.84

+2.33%↑

LLY

752.36

-0.66%↓

JNJ

151.72

+0.28%↑

UNH

304.64

+4.6%↑

ABBV

183.5

-0.25%↓

NVO

65.84

+2.33%↑

LLY

752.36

-0.66%↓

JNJ

151.72

+0.28%↑

UNH

304.64

+4.6%↑

ABBV

183.5

-0.25%↓

NVO

65.84

+2.33%↑

Search

Establishment Labs Holdings Inc

Open

SectorGezondheidszorg

35.24 -2.38

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

34.97

Max

35.56

Belangrijke statistieken

By Trading Economics

Inkomsten

14M

-21M

Verkoop

-3.1M

41M

EPS

-0.7

Winstmarge

-50.052

Werknemers

1,018

EBITDA

-19M

-28M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+55.67% upside

Dividenden

By Dow Jones

Volgende Winsten

5 aug 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-13M

1B

Vorige openingsprijs

37.62

Vorige sluitingsprijs

35.24

Nieuwssentiment

By Acuity

100%

0%

367 / 382 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Very Strong Bullish Evidence

Establishment Labs Holdings Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

2 okt 2024, 16:43 UTC

Belangrijke Marktbewegers

Establishment Labs Shares Climb on High Demand for FDA-Approved Breast Motiva Implants

27 sep 2024, 10:33 UTC

Belangrijke Marktbewegers

Establishment Labs Shares Surge Premarket on FDA Breast Implant Approval

Peer Vergelijking

Prijswijziging

Establishment Labs Holdings Inc Prognose

Koersdoel

By TipRanks

55.67% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 56.29 USD  55.67%

Hoogste 62 USD

Laagste 45 USD

Gebaseerd op 7 Wall Street-analisten die 12-maands prijsdoelen bieden voor Establishment Labs Holdings Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

7 ratings

7

Buy

0

Hold

0

Sell

Technische score

By Trading Central

30.5 / N/ASteun & Weerstand

Korte Termijn

Very Strong Bullish Evidence

Gemiddeld Termijn

Strong Bearish Evidence

Lange Termijn

Strong Bearish Evidence

Sentiment

By Acuity

367 / 382 Rangschikking in Gezondheidszorg

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Establishment Labs Holdings Inc

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.